In a randomised crossover trial in adults with type 2 diabetes on haemodialysis, real-time CGM did not change time below 70 mg/dL versus fingerstick testing (mean 1.17% vs 1.29%; P=0.28), though time in range was higher (63.4% vs 54.5%).
RCT
Galindo et al. Real-Time Continuous Glucose Monitoring Among People With Type 2 Diabetes and End-Stage Kidney Failure Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial